Helicobacter pylori Infection and Light Chain Gammopathy

الملخص EN

Objective.

Helicobacter pylori provokes a host of immune alterations upon colonizing the gastric mucosa.

Design.

We report 22 individuals with confirmed Helicobacter pylori infection who were also managed for the concurrent elevation of immunoglobulin free light chain (kappa and lambda) levels.

Result.

Of the 22 patients, 15 patients (68.2%) had elevated free light chain levels: 6 patients (40%) had only kappa chain elevation, 2 patients (13.3%) had only lambda chain elevation, and 7 patients (46.7%) had both kappa and lambda chain elevation.

Twenty out of the 22 patients (90.9%) were microbiologically confirmed cured with 3 patients being lost to follow-up for repeat levels.

Of the 3 patients who were lost to follow-up, 1 patient had only kappa chain elevation, 1 patient had only lambda chain elevation, and 1 patient had both kappa and lambda chain elevation.

For those who were cured (19 patients), 5 patients with kappa elevation had normalized values, 4 patients with lambda elevation had normalized values, and 2 patients with combined kappa and lambda elevation had normalized values.

For 6 out of the 19 patients, the light chain levels remained elevated.

Conclusion.

We speculate that the Helicobacter pylori infection disrupts the immunoglobulin system with potential implications being discussed below.